India's healthcare landscape is witnessing a surge in vector-borne diseases (VBDs), posing a significant challenge to public health. VBDs such as dengue, malaria, and chikungunya, transmitted by vectors like mosquitoes, ticks, and fleas, are increasingly prevalent, with climate change and urbanisation contributing to their spread.
India's tropical climate and rapid urbanisation create an ideal environment for vectors, leading to a high incidence of VBDs. The World Health Organisation (WHO) reports that India has the world's highest number of dengue cases, with malaria and chikungunya also being widespread. The burden of these diseases is not only medical but also economic, with direct and indirect costs impacting the country's development.
Despite efforts to control VBDs, several challenges persist. These include inadequate surveillance, lack of public awareness, and insufficient vector control measures. Additionally, climate change exacerbates the problem by extending the vectors' breeding seasons and geographical range. The increasing resistance of vectors to insecticides further complicates control efforts.
Addressing VBDs requires a multi-pronged approach. This includes strengthening surveillance systems, enhancing public awareness, and implementing effective vector control strategies. Furthermore, research into new diagnostic methods, vaccines, and treatments is crucial. Collaboration between various stakeholders, including government agencies, healthcare providers, and communities, is essential for a comprehensive response.
The rising tide of VBDs in India is a pressing public health issue requiring urgent attention. By unmasking the complexities of this issue and implementing effective strategies, it is possible to mitigate the impact of these diseases. As healthcare professionals, our role in this endeavour is pivotal, from treating patients to conducting research and advocating for better policies. The battle against VBDs is indeed challenging, but with concerted effort and collaboration, it is a battle that can be won.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation